Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-23-095014

Options or other derivatives

  • Director acquired 12,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
BIZZARI JEAN-PIERRE Director 2023-08-23 Grant or award · Stock Options (Right to Buy) +12,500 12,500 D
Loading xslF345X05/tm2324788-3_4seq1.xml…